NCT00477893 - Danish Multicenter Study of Adalimumab in Spondyloarthritis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2013

Conditions

Spondyloarthritis

Interventions

DRUG

Adalimumab

sc. injection Humira 40 mg every other week, from week 0 or 12 to the end of study

DRUG

Placebo

sc. inj. placebo every other week, week 0, 2, 4, 6, 8, and 10.

Trial Locations (13)

Department of Radiology, Aabenraa Hospital, Aabenraa

Department of Radiology, Århus University Hospital, Aarhus

Department of Radiology, Herlev University Hospital, Copenhagen

Department of Rheumatology, Bispebjerg University Hospital, Copenhagen

Department of Rheumatology, Gentofte University Hospital, Copenhagen

Department of Rheumatology, Glostrup University Hospital, Copenhagen

Department of Rheumatology, Herlev University Hospital, Copenhagen

Department of Rheumatology, Hvidovre University Hospital, Copenhagen

King Christian X´s Hospital of Rheumatic Diseases, Gråsten

Department of Rheumatology, Hørsholm Hospital, Hørsholm

Department of Rheumatology, Slagelse Hospital, Slagelse

Department of Radiology, Vejle Hospital,, Vejle

Department of Rheumatology, Vejle Hospital, Vejle